Test
For use with Clinitek 50, 100, Status Family of Urine Chemistry Analyzers
Each vial contains 100 mg of lyophilized Bovine IgG. The product was in 0.01M PBS, pH 7.4.
Manufactured in a state-of-the-art facility in New Zealand using a chromatographic extraction process, under Quality Systems that are ISO Certified and audited to cGMP Principles.
For the Qualitative Detection of Albumin in Urine
Type | Exton Qualitative Reagent |
---|
BCG Albumin Assay Kit is a quantitative colorimetric albumin determination at 620 nm.
For use with albumin test kit
Germaine™ Laboratories AimStrip™ MACRE Strips are dipstick reagent strips for the qualitative detection of Microalbumin and Creatinine
Germaine™ Laboratories MicroAlbumin 2-1 Combo Dipstick reagent strips are for the qualitative detection of Microalbumin and Creatinine
BCP Albumin Assay Kit is a quantitative colorimetric albumin determination at 610 nm.
The DetectX Urinary Creatinine Detection kits are designed to quantitatively measure creatinine in urine samples. A NIST calibrated creatinine standard is used to standardize the assay.
The Sovicell TRANSIL PPB Binding Kit estimates the binding of drugs to human serum albumin (HSA) and human alpha-1 glycoprotein (AGP/AAG) at a physiological ratio to predict plasma protein binding. Internal quality controls provide easy assessment of recovery, experiment and data quality.
The Sovicell TRANSIL RSA Binding Kit estimates the binding of drugs to rat serum albumin (RSA) and predicts the plasma protein binding. The assay kit measures the affinity constant (KD) of drugs to albumin and hence allows the calculation of albumin binding even under disease and physiological states that alter the albumin content of human serum. Internal quality controls provide easy assessment of recovery, experiment and data quality.
The TRANSIL Brain Absorption kit estimates the binding of drugs to brain tissue and predicts the disposition of drugs into brain. It measures the affinity of drugs to reconstituted porcine brain membranes. The brain membrane affinity is used to estimate the brain tissue binding and to predict the brain-to-plasma distribution via a hybrid model that also incorporates the drug’s polar surface area and its plasma protein binding. Internal quality controls provide easy assessment of recovery, experiment and data quality.